Day 2 – Fri, February 23rd, 2024
Registration & GENAP Opening Speech
-
Innovative Aseptic Techniques for High Potent Products
-
Section 4: Improving Aseptic Techniques
Scaling Up with Precision: Navigating Large-Scale GCT Production for Tomorrow’s Therapies
-
Section 4: Large-Scale GCT Production
Optimizing GCT Manufacturing: Process Enhancements for Efficiency
-
Section 4: Large-Scale GCT Production
Advanced Aseptic Techniques: Case Studies in Optimizing Sterility Assurance
-
Section 4: Improving Aseptic Techniques
Adaptive Strategies in Aseptic Fill-Finish: Navigating Complex Challenges and Novel Technologies
-
Section 4: Improving Aseptic Techniques
Strategies for Successful GCT Product Commercialization in Today’s Market
-
Section 4: Large-Scale GCT Production
Morning Coffee Break
-
During this networking break, Sponsors will also have the opportunity to deliver a 5-minute presentation at their designated exhibition space to engage with all our attendees during scheduled times.
Bioconvergence of Aseptic Processing and Gene & Cell Therapy: Synergistic Advancements in Sterility and Vector Production
-
Section 5: Driving Synergies Between APT and GCT
Bioconvergence of Aseptic Processing and Gene & Cell Therapy: Synergistic Advancements in Sterility and Vector Production
-
Section 5: Driving Synergies Between APT and GCT
Innovative Collaborative R&D: Fusing Aseptic Processing and Gene & Cell Therapy for Advanced Biopharmaceuticals
-
Section 5: Driving Synergies Between APT and GCT
Panel Discussion: Navigating Annex 1 Guidelines for Enhanced Sterile Product Manufacturing
-
Interpreting the Impact of Annex 1 Revisions on Sterile Product Manufacturing
Best Practices for Achieving Compliance and Maintaining Quality in Sterile Production
Strategies in Vector Development for Gene and Cell Therapies
-
Section 6: Advancements in Vector Development
Vector Design and Optimization: A Comparative Analysis for APT and GCT
-
Section 6: Advancements in Vector Development
End of GENAP Summit 2024
-